Notice ID: 7f8b4200eced493a94ae3addc7884dd3Award NoticeAwarded
Multi-Taxa Ecotoxicity of Novel Fluorine Free Foam versus New Generation Short Chain PFAS Aqueous Film Forming Foam Products
Awarded on June 4, 2020. Full description on SAM.gov.
Awarded tounder W912HQ20C0021 (source: SAM.gov award notice)• $1.7M
Overview
- Posted
- June 4, 2020
- Notice type
- Award Notice
- NAICS
- 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Agency
- Department of War
Notice details
- Place of performance
- Hunt Valley, MD, 21031-1124
- Last updated
- Dec 6, 2025
- Award date
- Jun 4, 2020
- Award amount (SAM.gov award notice)
- $1.7M
Identifiers
- Solicitation number
- W912HQ19S0006
- Notice ID
- 7f8b4200eced493a94ae3addc7884dd3
- Award number (PIID)
- W912HQ20C0021
Description
An award was issued to EA Engineering, Science, and Technology, Inc., PBC on 4 June 2020 against BAA W912HQ19S0006 for their proposal entitled Multi-Taxa Ecotoxicity of Novel Fluorine Free Foam versus New Generation Short Chain PFAS Aqueous Film Forming Foam Products.
Award Overview
Award Number
W912HQ20C0021
Award Amount (SAM.gov award notice)
$1.7M
Award Date
Jun 4, 2020
Awardee
Awardee UEI
LEEMJD9WKDC9
Awardee CAGE Code
7V713
Original Solicitation
Notice ID: 7f8b4200eced493a94ae3addc7884dd3
Posted Date: Jun 4, 2020
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $1.2MSigned Jul 21, 2026
- $6.0MSigned Jul 20, 2026
- $3.0MSigned Jun 30, 2026
- $355.9KSigned Jun 25, 2026
- $5.8MSigned May 27, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
W912HQ19S0006- Awarded
This opportunity has been awarded.
- AwardedCurrentJun 4, 2020
Multi-Taxa Ecotoxicity of Novel Fluorine Free Foam versus New Generation Short Chain PFAS Aqueous Film Forming Foam Products
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The United States Army Contracting Command-Detroit Arsenal on behalf of Project Manager Solider Survivability (PM SSV) intends to solicit on a sole source basis under the statutory authority permitting Other than Full and Open Competition 10 United States Code 3204(b)(B)(ii), as implemented by Federal Acquisition Regulation 6.302-1(a)(2)(iii)(B), Services may be deemed to be available only from the original source in the case of follow-on contract for the continued provision of highly specialized services when it is likely that award to any other source would result in unacceptable delays in fulfilling the agency’s requirements, to DCS Corporation, 6909 Metro Park Drive Suite 500, Alexandria Virginia 22310 for the procurement of four (4) months of Systems Engineering and Technical Assistance (SETA) Support Services. The procurement of the services will be executed via a modification to an existing award. This notice is not a request for proposals or quotations. Requests for copies of a solicitation in response to this notice will not be honored or acknowledged. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government. Interested parties may identify their capabilities by responding to this requirement, no later than 3:30 pm EST, 14 August 2026. All information submitted should support the offeror's capability to provide the services required, and shall be furnished at no cost or obligation to the Government. Responses must be in writing and must provide clear and concise documentation indicating an offeror's bona fide capability to provide these services. Verbal responses are not acceptable and will not be considered. Responses shall be submitted via email to lieselotte.h.pattee.civ@army.mil and theresa.s.quick.civ@army.mil. | - | Special Notice | 11/27/2026 |
The Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), Medical - Accelerated Defense Pharmaceuticals program is formally requesting information from capable companies. The objective of the program is to progress the development of existing prophylactic MCMs manufactured on existing platform technologies that support clinical safety and/or possess strong preclinical immunogenicity, safety, and efficacy data. | - | Special Notice | 11/18/2026 |
See attached Justification And Approval document. | - | Sole Source / J&A | Open |
W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated computational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning to enable preparedness and facilitate rapid response to protect the warfighter from a diverse and dynamic threat space. GUIDE impacts the discovery and design of biological products (e.g., monoclonal antibodies and vaccines) as well as small molecule drugs by simultaneously optimizing critical quality attributes of safety, efficacy, manufacturability and pharmacokinetics/pharmacodynamics while concurrently accounting for critical design attributes affecting developability and biophysical properties. GUIDE is a collaboration between U.S. interagency, academic and industry partners and is closely linked to the Accelerated Antibodies, Rapid Access to Products in Development (RAPID), Vaccine Acceleration by Modular Progression (VAMP), and Rapid Acquisition and Investigation of Drugs for Repurposing (RAIDR) programs. Additional information may be found at: https://armyeitaas.sharepoint-mil.us/sites/usaasc-jpeocbrnd The GUIDE Program will be carried out under the terms of a Participant Basic Agreement (PBA). The PBA is available for qualified entities interested in participating. Entities wishing to participate shall submit an email requesting participation to the Primary Point of Contact identified below demonstrating technical relevancy in development of Medical Countermeasures. Material that is only advertisement or marketing material in nature is not desired. Entities requesting participation will be reviewed by the program office to determine their technical relevance to the program, and subsequently invited to participate as a qualified entity. Projects awarded resulting from participation in the GUIDE Program may be awarded under authority 10 U.S.C. 4022 and 10 U.S.C. 4023. Agreements awarded pursuant to 10 U.S.C. 4022 and 10 U.S.C. 4023 will NOT be made or issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), FAR Part 6 or any other FAR based regulation. The U.S. Army Contracting Command - Aberdeen Proving Ground (ACC-APG), Edgewood Contracting Division is supporting JPL EB in the execution of the GUIDE Program. Primary Point of Contacts: Joseph McCaffery Email Address: joseph.w.mccaffery2.civ@army.mil Keith Pereira Email Address: keith.d.pereira.civ@army.mil Please send technical and administrative questions and inquiries to the Primary Point of Contacts to facilitate communication on all matters relating to this Announcement. The Government is prohibited from soliciting and awarding actions to contractors that have engaged or are suspected to have engaged in criminal, fraudulent, or seriously improper conduct. Prospective vendors shall complete electronic annual representations and certifications at SAM. There is a requirement that prospective awardees MUST be registered in the System for Award Management (SAM) database prior to submitting an invoice and through final payment of any agreement resulting from any award. Vendors that are not registered should consider applying for registration immediately. To remain registered in the SAM database after the initial registration, the Vendors is required to review and update on an annual basis from the date of initial registration (or subsequent updates) its information in the SAM database to ensure it is current, accurate and complete. This notification is for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. | - | Special Notice | 10/18/2028 |
SEE AMENDMENT 0009 for updated Attachment 01. All changes are highlighted in Yellow. | - | Special Notice | 10/31/2027 |
Additional Details
Solicitation Number
W912HQ19S0006
Archive Date
Jun 19, 2020
Office Address
ALEXANDRIA, VA, 22315-3860